Refreshing results…
Flotetuzumab as Salvage Immunotherapy for Refractory Acute Myeloid Leukemia
UploadIbrutinib added to 10-day decitabine for older patients with AML and higher risk MDS
Download from doi.orgMissing publications? Search for publications with a matching author name.